Approval Year
Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 13:26:46 UTC 2023
by
admin
on
Sat Dec 16 13:26:46 UTC 2023
|
Source Materials Class | ORGANISM |
Source Materials Type | AUTOLOGOUS HUMAN |
Source Materials State | LIVE |
Source Materials Parent | |
Part | BLOOD |
Fraction Material Type | CELL |
Fraction Name | CD4 AND CD8 POSITIVE |
Record UNII |
U2I8T43Y7R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C129826
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
||
|
FDA ORPHAN DRUG |
515615
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
||
|
FDA ORPHAN DRUG |
735920
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
||
|
NCI_THESAURUS |
C28681
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
||
|
FDA ORPHAN DRUG |
423914
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
||
|
FDA ORPHAN DRUG |
515915
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
||
|
FDA ORPHAN DRUG |
740320
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
||
|
NCI_THESAURUS |
C137999
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/15/1553
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DE-33
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
PRIMARY | |||
|
DB13915
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
PRIMARY | |||
|
1987398
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
PRIMARY | |||
|
U2I8T43Y7R
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
PRIMARY | |||
|
C120309
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
PRIMARY | |||
|
10518
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
PRIMARY | |||
|
U2I8T43Y7R
Created by
admin on Sat Dec 16 13:26:46 UTC 2023 , Edited by admin on Sat Dec 16 13:26:46 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Agent Modifications
Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
---|---|---|---|---|---|
CULTURE | ACTIVATOR | IMMUNOLOGICAL | MUROMONAB-CD3 | JGA39ICE2V | |
CULTURE | GROWTH FACTOR | BIOLOGICAL | ALDESLEUKIN | M89N0Q7EQR | |
TRANSDUCTION | ANTIGEN EXPRESSION | TRANSDUCING VECTOR |
|
UNSPECIFIED SUBSTANCE | 0f2235db |
Structural Modifications
Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
---|---|---|---|---|---|---|
MOIETY | ANTI-CD-19 CD28/CD3-ZETA CHIMERIC ANTIGEN RECEPTOR (KTE-CD19) | V248BS56D0 |